发明名称 2-(Pyridin-2-yl)-1, 7-Diaza-Spiro [4.4] Nonane-6-One Compound as Voltage-Gated Sodium Channel Modulator
摘要 The invention relates to spiro derivatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.
申请公布号 US2016185758(A1) 申请公布日期 2016.06.30
申请号 US201615053445 申请日期 2016.02.25
申请人 CONVERGENCE PHARMACEUTICALS LIMITED 发明人 Witty David R.;MacPherson David T.;Giblin Gerard M.P.;Stanway Steven J.
分类号 C07D401/14 主分类号 C07D401/14
代理机构 代理人
主权项
地址 London GB